Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Deeba Hussain has worked on the following 152 EPO patent applications which have been published in the last five years:

EP11798821

NOVEL HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS

IPC classification:
A01N 43/56, C07D 209/48, C07D 231/56, C07D 235/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11775552

INHIBITORS OF PHOSPHOINOSITIDE DEPENDENT KINASE 1 (PDK1)

IPC classification:
A61K 31/33, A61K 31/385, A61P 35/00, C07D 417/04, C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP11756781

ENDOSOMOLYTIC POLY(AMIDOAMINE) DISULFIDE POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES

IPC classification:
A61K 31/74, A61K 31/785
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11822388

TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/095, A61K 31/655
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11825713

NOVEL THIAZOL-CARBOXIMIDE DERIVATIVES AS PDK1 INHIBITORS

IPC classification:
A61K 31/425, C07D 277/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11836931

NOVEL HETEROARYL-CARBOXAMIDE DERIVATIVES AS PDK1 INHIBITORS

IPC classification:
A61K 31/425, A61K 31/44, A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11772684

INHIBITORS OF AKT ACTIVITY

IPC classification:
A61K 31/135, A61K 31/425
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP11807297

TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/535
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11836930

NOVEL THIAZOLE-CARBOXAMIDE DERIVATIVES AS PDK1 INHIBITORS

IPC classification:
A01N 43/40, A61K 31/425, A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11825711

CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA AAA COUPLING

IPC classification:
C07H 21/02, C07H 21/04, C12P 19/34
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11810314

ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/00, A61K 31/55, C07D 235/06
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12777344

AMIDATION PROCESS

IPC classification:
C07C 231/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12709453

PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES

IPC classification:
A61K 31/445, C07D 207/12, C07D 207/273, C07D 207/48, C07D 211/46, C07D 211/96, C07D 223/08, C07D 309/12, C07D 401/04, C07D 401/06, C07D 401/10, C07D 401/14, C07D 403/04, C07D 403/10, C07D 405/12
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11174570

4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors

IPC classification:
A61K 31/4985, A61P 19/08, A61P 29/00, A61P 31/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 519/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12779616

DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES

IPC classification:
A01N 33/24, A61K 31/15, C07C 243/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12789446

ARYLOXYMETHYL CYCLOPROPANE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12776497

HETEROCYCLIC COMPOUNDS AS B-RAF INHIBITORS FOR TREATMENT OF CANCER

IPC classification:
A01N 37/12, A61K 31/195
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11825728

FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS

IPC classification:
A01N 43/38, A61K 31/40, C07D 401/04, C07D 401/14, C07D 405/14, C07D 417/14, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11766711

PREPARATION OF LIPID NANOPARTICLES

IPC classification:
A61K 9/127
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11822416

NOVEL SINGLE CHEMICAL ENTITIES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES

IPC classification:
C12P 21/06
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP11836946

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)

IPC classification:
C07H 21/02, C12N 15/11
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12825316

BENZOPIPERAZINE DERIVATIVES AS CETP INHIBITORS

IPC classification:
C07D 243/00, C07D 487/00, C07D 498/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12826237

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11831236

FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04, C07D 487/14, C07D 495/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12743963

KISSPEPTIDE-PENTASACCHARIDE CONJUGATES

IPC classification:
A61K 47/48, A61P 15/08
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12832050

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12746994

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A61K 31/165, A61P 3/10, A61P 19/00, A61P 19/10, C07C 317/32
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP11836944

DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES

IPC classification:
A61K 31/655, A61P 9/12, C07D 207/12, C07D 207/16, C07D 207/273, C07D 307/20, C07D 309/12, C07D 401/04, C07D 401/12, C07D 403/04, C07D 403/10, C07D 413/04, C07D 413/10, C07D 417/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
The patent has been granted
EP12834135

PYRAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12833774

TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12833256

IMIDAZOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12796872

RNA INTERFERENCE MEDIATED INHIBITION OF ISOCITRATE DEHYDROGENASE (IDH1) GENE EXPRESSION

IPC classification:
A61K 31/7088, C07H 21/02
Applicant:
Merck & Co. Inc.
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11820590

RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
Merck & Co. Inc.
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP12838891

TRIAZOLYL PDE10 INHIBITORS

IPC classification:
A01N 43/38
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12839780

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/50
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12840391

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/50
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12839466

PHARMACEUTICAL COMPOSITIONS THAT INHIBIT DISPROPORTIONATION

IPC classification:
A01N 25/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12839960

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/50
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12844384

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/4965, C07D 241/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12843432

FACTOR IXA INHIBITORS

IPC classification:
A61K 31/4412
Applicant:
Merck & Co. Inc.
Applicant:
Mochida Pharmaceutical Co Ltd
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12844606

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/4965, C07D 241/08
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12844023

SUBSTITUTED PIPERIDINYL COMPOUNDS USEFUL AS GPR119 AGONISTS

IPC classification:
A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12843484

PARI-MUTUEL PREDICTION MARKETS AND THEIR USES

IPC classification:
G06Q 40/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12781551

FUSED BICYCLIC OXAZOLIDINONE CETP INHIBITOR

IPC classification:
A61K 31/4188, A61P 9/10, C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12845954

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A01N 29/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12846651

PROCESS FOR A CETP INHIBITOR

IPC classification:
A01N 43/76
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12845426

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12849788

SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP14174698

Composition for inhibition of cathepsin K

IPC classification:
A61K 9/08, A61K 9/20, A61K 9/48, A61K 31/275, A61K 31/415, A61K 31/427, A61K 31/44, A61K 31/592, A61K 31/66, A61K 45/06, A61P 19/10
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12770627

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/416, A61K 31/44, A61P 3/00, A61P 9/00, C07D 231/56, C07D 401/04, C07D 413/06
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12857488

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A01N 43/58
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11820420

SINGLE-STRANDED RNAi AGENTS CONTAINING AN INTERNAL, NON-NUCLEIC ACID SPACER

IPC classification:
C12N 15/11, C12N 15/113, C12P 19/34
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14176452

Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors

IPC classification:
A61K 31/4439, A61P 29/00, A61P 35/00, C07D 401/10
Applicant:
MSD Italia S.r.l.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14173412

Heterocyclic compounds as factor IXA inhibitors.

IPC classification:
A61K 31/415, A61K 31/4152, A61K 31/4155, A61K 31/416, A61P 7/02, C07D 231/18, C07D 401/04, C07D 401/14, C07D 403/04, C07D 403/14, C07D 413/04, C07D 413/14, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12800644

PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS WITH SIMVASTATIN

IPC classification:
A61K 9/16, A61K 9/28
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12804259

PROCESS FOR PREPARING CHIRAL DIPEPTIDYL PEPTIDASE-IV INHIBITORS

IPC classification:
A61K 31/4439, A61K 31/4985, A61K 31/513
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12776492

ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/64, A61K 31/41, A61K 45/06, C07D 471/04, C07D 487/04, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12817088

FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS

IPC classification:
A01N 43/90, A61K 31/519, C07D 487/14, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13749397

DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

IPC classification:
A61K 31/4162, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13757283

PREPARATION AND USE OF BICYCLIC HIMBACINE DERIVATIVES AS PAR-RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11766550

NOVEL SINGLE CHEMICAL ENTITIES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES

IPC classification:
A61K 31/713, A61K 47/48, C07H 21/02
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13767554

ASYMMETRIC SYNTHESIS FOR PREPARING FLUOROLEUCINE ALKYL ESTERS

IPC classification:
C07C 17/00, C07C 229/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13769291

PREDICTIVE BIOMARKER USEFUL FOR CANCER THERAPY MEDIATED BY A CDK INHIBITOR

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769309

PROCESS FOR PREPARING FLUOROLEUCINE ALKYL ESTERS

IPC classification:
C07C 229/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769216

THROMBIN INHIBITORS

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12844405

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

IPC classification:
A61K 9/66
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12836652

SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

IPC classification:
A61K 31/445, A61P 3/04, A61P 3/10, C07D 401/08
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13784511

CYCLIC AMINE SUBSTITUTED HETEROCYCLIC CETP INHIBITORS

IPC classification:
A61K 31/443
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13772609

ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/64, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP13816893

PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS SA2493 PROTEIN

IPC classification:
A61K 39/02, A61K 39/085
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13823622

TREATING DIABETES WITH DIPEPTIDYL PEPTIDASE-IV INHIBITORS

IPC classification:
A61K 31/4439, A61P 3/10, C07D 487/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13822862

TREATING DIABETES WITH DIPEPTIDYL PEPTIDASE-IV INHIBITORS

IPC classification:
A61K 31/4162, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13745315

SPIRO - FUSED PIPERIDINE DERIVATIVES FOR USE AS INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/438, A61P 9/12, C07D 471/10, C07D 471/20, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13750427

ANTIDIABETIC TRICYCLIC COMPOUNDS

IPC classification:
A61K 31/435, A61P 3/04, A61P 3/06, A61P 3/10, C07D 221/16, C07D 401/12, C07D 401/14, C07F 9/40
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13830944

NOVEL BENZIMIDAZOLE TETRAHYDROFURAN DERIVATIVES

IPC classification:
A61K 31/415, A61K 31/4184, A61K 31/454, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13830714

NOVEL AZABENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES

IPC classification:
A61K 31/415, A61K 31/4184, A61K 31/454, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13830277

NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES

IPC classification:
A61K 31/415, A61K 31/4184, A61K 31/454, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13831336

NOVEL AZABENZIMIDAZOLE TETRAHYDROFURAN DERIVATIVES

IPC classification:
A61K 31/415, A61K 31/4184, A61K 31/454, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13830916

NOVEL BENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES

IPC classification:
A01N 43/50, A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13841430

TRIAZOLYL DERIVATIVES AS SYK INHIBITORS

IPC classification:
A61K 31/506, A61P 11/06, A61P 29/00, A61P 35/00, C07D 239/50, C07D 417/12, C07D 417/14
Applicant:
Merck Canada Inc.
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13843259

INDOLINE COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITIORS RELATED APPLICATIONS

IPC classification:
A61K 31/4164, A61K 31/4439
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13831487

NOVEL BENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES

IPC classification:
A01N 43/50, A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13853278

PRODRUG BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS

IPC classification:
A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13852548

AMINO-PYRIDINE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

IPC classification:
A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13855335

PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA

IPC classification:
A61K 31/52, A61K 31/522, A61P 11/00, A61P 19/02, A61P 35/00, A61P 37/00, C07D 473/00, C07D 473/30, C07D 473/38
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13855780

PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA

IPC classification:
A61K 31/52, A61P 11/00, A61P 19/02, A61P 35/00, A61P 37/00, C07D 473/34
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13857464

THROMBIN INHIBITORS

IPC classification:
A61K 31/165, A61K 31/401, A61P 7/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13843517

SUBSTITUTED ISOQUINOLINES AS CRTH2 RECEPTOR MODULATORS

IPC classification:
A01N 43/42, A61K 31/4245, A61K 31/47
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13859070

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP13860451

CONDITIONAL REPLICATING VIRAL VECTORS

IPC classification:
C12N 15/86
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13861998

AMINO-PYRIMIDINE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
A61K 31/506, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864999

NOVEL GLUCOKINASE ACTIVATOR COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

IPC classification:
C07F 9/32
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864370

THIAZOLE-SUBSTITUTED AMINOPYRIDINES AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/44, A61P 35/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13873301

FACTOR IXA INHIBITORS

IPC classification:
A61K 31/5377, C07D 413/12
Applicant:
Merck & Co. Inc.
Applicant:
Mochida Pharmaceutical Co Ltd
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13865060

INDAZOLE COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/46, A61K 31/415, C07D 401/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13863880

FACTOR IXa INHIBITORS

IPC classification:
A61K 31/5377, C07D 413/12
Applicant:
Merck & Co. Inc.
Applicant:
Mochida Pharmaceutical Co Ltd
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13866418

FACTOR IXA INHIBITORS

IPC classification:
A61K 31/5377, C07D 413/12
Applicant:
Merck & Co. Inc.
Applicant:
Mochida Pharmaceutical Co Ltd
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13865518

THERAPEUTIC THIAZOLIDINONE COMPOUNDS

IPC classification:
A61K 31/426, A61P 9/10, C07D 277/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13865292

SPIROCYCLIC CETP INHIBITORS

IPC classification:
A61K 31/421, A61P 9/10, C07D 263/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP11829806

LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY

IPC classification:
A61K 9/14, A61K 9/51, C07C 217/08, C12N 15/88
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14757359

IMMOBILIZED TRANSAMINASES AND PROCESS FOR MAKING AND USING IMMOBILIZED TRANSAMINASE

IPC classification:
C12N 9/10, C12N 9/96, C12N 11/08
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14754282

ANTIDIABETIC BICYCLIC COMPOUNDS

IPC classification:
A61K 31/357
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14770645

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/438, C07D 471/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14768236

PROCESS FOR PREPARING BETA 3 AGONISTS AND INTERMEDIATES

IPC classification:
A61K 31/40
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14763846

NOVEL INDOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS

IPC classification:
A61K 31/404, A61K 31/41, A61K 31/4353, A61K 31/495, A61K 31/5365, A61P 3/10, C07D 209/12, C07D 209/30, C07D 403/10, C07D 471/04, C07D 487/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14769986

IMMOBILIZED KETOREDUCTASES AND PROCESS FOR MAKING AND USING IMMOBILIZED KETOREDUCTASE

IPC classification:
C12N 9/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11841433

POLY(AMIDE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES

IPC classification:
A61K 31/7088, C08G 69/10
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14770170

GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/437, A61K 31/444, A61P 19/02, A61P 29/00, A61P 37/00, C07D 205/04, C07D 211/00, C07D 309/02, C07D 471/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14767371

CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/437, A61K 31/4375, A61P 25/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 487/08, C07D 487/14
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14770056

ACYCLIC CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/437, A61K 31/4375, A61P 25/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 487/08, C07D 487/14
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14767458

N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14773353

METHODS FOR PREPARING SGLT2 INHIBITORS

IPC classification:
A61K 31/70
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15182403

PROCESS FOR SYNTHESIZING A CETP INHIBITOR

IPC classification:
A61K 31/421, C07D 263/22
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14788786

THIAZOLE-SUBSTITUTED AMINOPYRIMIDINES AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/497, A61P 29/00, C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14788026

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/426, A61K 31/44, A61K 31/53
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11820437

FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN

IPC classification:
A61K 31/4375, A61P 35/00, C07D 471/14, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11759963

PROCESS FOR SYNTHESIZING 6-BROMO-3-(1-METHYL-1H-PYRAZOL-4-YL)-5-(3(R)-PIPERIDINYL)PYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE

IPC classification:
C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11820438

NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS

IPC classification:
A01N 43/42, A61K 31/52
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11836910

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61P 9/00, C07D 213/72, C07D 401/04, C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11849978

INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS

IPC classification:
A61K 31/416, A61P 35/00, C07D 231/56, C07D 401/04, C07D 401/14, C07D 403/14, C07D 417/04, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11730563

(11 BETA,17 ALPHA)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY-19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE

IPC classification:
A61K 31/58, A61P 5/36, C07J 21/00, G01N 33/74
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11790268

NOVEL LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY

IPC classification:
A61K 9/127, A61K 47/18, C07C 43/15, C07C 217/44, C07C 217/46, C07D 205/04, C07D 207/08, C07D 295/084, C07D 317/28, C12N 15/87
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP11760012

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61K 31/505, C07D 401/14, C07D 403/14, C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11784021

DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES

IPC classification:
A01N 33/26, A61K 31/13, A61K 31/15, C07B 59/00, C07C 291/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11836912

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/496
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14856821

GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE

IPC classification:
A61K 31/404, A61P 3/10, C07D 209/18
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11836899

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 213/61, C07D 271/12, C07D 295/13, C07D 295/15, C07D 295/155, C07D 307/88, C07D 309/30
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11787236

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A01N 43/90, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11720549

THIENO(2,3B)PYRAZINE COMPOUNDS AS B-RAF INHIBITORS

IPC classification:
A61K 31/4985, A61P 35/00, C07D 495/04
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11836937

CYCLIC AMINE SUBSTITUTED OXAZOLIDINONES AS CETP INHIBITORS

IPC classification:
A61K 31/422, A61K 31/4427, A61K 31/506, A61P 3/06, A61P 9/10, C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP14870931

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS

IPC classification:
C07D 307/91, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15759159

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/5377
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15760695

PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS

IPC classification:
C07D 241/36, C07D 281/10
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15715934

4'-SUBSTITUTED NUCLEOSIDE-DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/7064, A61K 31/7076, A61P 1/16, C07D 487/04, C07H 19/06, C07H 19/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15774282

PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/501, A61K 31/506, A61K 31/513
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15779184

FACTOR IXA INHIBITORS

IPC classification:
C07D 207/02, C07D 261/20, C07D 413/14
Applicant:
Merck & Co. Inc.
Applicant:
Mochida Pharmaceutical Co Ltd
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15780578

FACTOR IXA INHIBITORS

IPC classification:
C07D 207/02, C07D 261/20, C07D 413/14
Applicant:
Merck & Co. Inc.
Applicant:
Mochida Pharmaceutical Co Ltd
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15783339

FACTOR XIa INHIBITORS

IPC classification:
A61K 31/438, C07D 471/10, C07D 498/20
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15800524

FACTOR XIA INHIBITORS

IPC classification:
A61K 31/167, A61K 31/4192, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15821775

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15821391

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15829495

[5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS

IPC classification:
A61K 31/343, A61K 31/443, C07D 307/79
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15827597

FACTOR XIa INHIBITORS

IPC classification:
A61K 31/4184, A61P 7/02, C07D 401/06
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15827513

FACTOR XIa INHIBITORS

IPC classification:
A61P 7/02, C07D 401/02, C07D 401/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15756648

METHODS OF TREATING ACUTE MYELOID LEUKEMIA OR ACUTE LYMPHOID LEUKEMIA USING PHARMACEUTICAL COMPOSITIONS CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 9/20, A61K 31/551, A61K 47/26, A61P 35/02
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15837715

TETRAHYDROISOQUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2

IPC classification:
A61K 31/47, A61P 9/10, C07D 217/06
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15838154

ISOQUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2

IPC classification:
A61K 31/47, A61P 9/10, C07D 217/12
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15838912

TETRAHYDROISOQUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2

IPC classification:
A61K 31/47, A61P 9/10, C07D 217/06
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made

Please Sign in to use this feature